本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sarepta Therapeutics

97.19
-1.1800-1.20%
盘后97.190.00000.00%19:44 EDT
成交量:87.42万
成交额:8,558.53万
市值:94.31亿
市盈率:41.57
高:100.00
开:99.00
低:97.06
收:98.37
数据加载中...
2024/06/24

关联方拟减持公告

Form144|赛普拉高管Bilal Arif拟减持7859股,总价约126万美元
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals